Samer Ss Mahmoud1, Max Esser2,3, Arvind Jain2,3,4. 1. The Alfred Hospital, 55 Commercial Road, Melbourne, VIC, 3000, Australia. samermahmoud@me.com. 2. Department of Orthopaedic Surgery, The Alfred Hospital, Melbourne, Australia. 3. Associate Professor, Department of Surgery, Monash University, Melbourne, Australia. 4. Melbourne Bone and Joint Clinic, 27 Erin Street Richmond, Melbourne, VIC, 3121, Australia.
Abstract
PURPOSE: Rates of venous thromboembolic events (VTEs) as high as 41% deep vein thrombosis (DVT) were reported in association with pelvic and acetabular fractures (PAFs). There is no clear consensus on VTE prophylaxis for PAFs. Extracting evidence-based guidelines is key to overcome this challenging complication. The aims of this review are (A) to highlight the incidence of VTEs in PAFs, (B) to examine the screening and prophylaxis methods available in the current literature, and (C) direct future creation of a best practice protocol to reduce the risk of VTE in PAFs. METHODS: We performed a systematic search of Medline, EMBASE databases, and the Cochrane library. MESH terms were used to identify studies pertinent to VTE in PAFs, including incidence, prophylaxis, and screening. RESULTS: In total, 28 studies were identified and grouped into four categories including incidence, screening, prophylaxis, and the use of inferior vena cava filters (IVCFs). Incidence of VTE ranged from 0.21 to 41% for DVT and 0 to 21.7% for PE. Nine studies screened 1360 patients using different imaging modalities. Ten articles, 2836 patients, examined different thromboprophylaxis protocols. Two out of three studies investigating the use of IVCF showed significant reduction of the rates of PE. CONCLUSION: Incidence of VTE in PAF varies significantly with different protocols. The current literature shows that screening is still controversial. The combination of chemical and mechanical prophylaxis starting at 24 hours from the injury would provide the best protection. Guidelines were extracted; however, higher level multicenter studies are still required to guide future protocols.
PURPOSE: Rates of venous thromboembolic events (VTEs) as high as 41% deep vein thrombosis (DVT) were reported in association with pelvic and acetabular fractures (PAFs). There is no clear consensus on VTE prophylaxis for PAFs. Extracting evidence-based guidelines is key to overcome this challenging complication. The aims of this review are (A) to highlight the incidence of VTEs in PAFs, (B) to examine the screening and prophylaxis methods available in the current literature, and (C) direct future creation of a best practice protocol to reduce the risk of VTE in PAFs. METHODS: We performed a systematic search of Medline, EMBASE databases, and the Cochrane library. MESH terms were used to identify studies pertinent to VTE in PAFs, including incidence, prophylaxis, and screening. RESULTS: In total, 28 studies were identified and grouped into four categories including incidence, screening, prophylaxis, and the use of inferior vena cava filters (IVCFs). Incidence of VTE ranged from 0.21 to 41% for DVT and 0 to 21.7% for PE. Nine studies screened 1360 patients using different imaging modalities. Ten articles, 2836 patients, examined different thromboprophylaxis protocols. Two out of three studies investigating the use of IVCF showed significant reduction of the rates of PE. CONCLUSION: Incidence of VTE in PAF varies significantly with different protocols. The current literature shows that screening is still controversial. The combination of chemical and mechanical prophylaxis starting at 24 hours from the injury would provide the best protection. Guidelines were extracted; however, higher level multicenter studies are still required to guide future protocols.
Authors: Jonathan A C Sterne; Jelena Savović; Matthew J Page; Roy G Elbers; Natalie S Blencowe; Isabelle Boutron; Christopher J Cates; Hung-Yuan Cheng; Mark S Corbett; Sandra M Eldridge; Jonathan R Emberson; Miguel A Hernán; Sally Hopewell; Asbjørn Hróbjartsson; Daniela R Junqueira; Peter Jüni; Jamie J Kirkham; Toby Lasserson; Tianjing Li; Alexandra McAleenan; Barnaby C Reeves; Sasha Shepperd; Ian Shrier; Lesley A Stewart; Kate Tilling; Ian R White; Penny F Whiting; Julian P T Higgins Journal: BMJ Date: 2019-08-28
Authors: Morgan Schellenberg; Elizabeth Benjamin; Kenji Inaba; Patrick Heindel; Subarna Biswas; Jennifer L Mooney; Demetrios Demetriades Journal: J Surg Res Date: 2020-10-08 Impact factor: 2.192
Authors: Ramesh Kumar Sen; Amit Kumar; Sujit Kumar Tripathy; Sameer Aggarwal; N Khandelwal; Sakthivel R R Manoharan Journal: Int Orthop Date: 2010-07-24 Impact factor: 3.075
Authors: J P Stannard; R S Riley; M D McClenney; R R Lopez-Ben; D A Volgas; J E Alonso Journal: J Bone Joint Surg Am Date: 2001-07 Impact factor: 5.284
Authors: Drake S Borer; Adam J Starr; Charles M Reinert; Ashutosh V Rao; Paul Weatherall; Daniel Thompson; Julie Champine; Alan L Jones Journal: J Orthop Trauma Date: 2005-02 Impact factor: 2.512